We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
As Congress considers reauthorization of two programs that encourage companies to gather information on drugs’ effects on children, witnesses at a recent hearing suggested improvements and debated the six months of exclusivity granted to manufacturers under one of the acts.
Witnesses at a Senate hearing debated the costs and risks of allowing imported pharmaceuticals, with some saying a proposed bill would cause “a flood” of dangerous counterfeit drugs into the country and others claiming it would improve safety.
The draft “Safe Drug Compounding Act of 2007” would stop illegal mass manufacturing of drugs while allowing patients access to legally compounded medications, the Consumer Health Alliance for Safe Medications (CHASM) said.
Reps. Henry Waxman (D-Calif.) and Edward Markey (D-Mass.) have introduced legislation they say goes further to strengthen the FDA’s drug safety review processes than the bill’s counterpart in the Senate.
A study claiming that two state pharmaceutical gift disclosure laws do not make payment information easily available to the public relied on inconsistent and mixed data, a top PhRMA official said.
Consumers Union is calling for changes to strengthen S.484, the “Enhancing Drug Safety and Innovation Act,” because the current version will not make a major difference in the FDA’s drug safety processes, the organization said.
Consumers Union is calling for changes to strengthen S.484, the “Enhancing Drug Safety and Innovation Act,” because the current version will not make a major difference in the FDA’s drug safety processes, the organization said.
Witnesses at a Senate hearing debated the costs and risks of allowing imported pharmaceuticals, with some saying a proposed bill would cause “a flood” of dangerous counterfeit drugs into the country and others claiming it would improve safety.
Witnesses at a Senate hearing debated the costs and risks of allowing imported pharmaceuticals, with some saying a proposed bill would cause “a flood” of dangerous counterfeit drugs into the country and others claiming it would improve safety.
The Senate Committee on Commerce, Science and Transportation is holding a hearing today on importing pharmaceuticals after lawmakers reintroduced a bill that would allow U.S. citizens to order drugs from FDA-approved Canadian pharmacies.